Two new studies describe the benefits of the antiviral drugs nirmatrelvir-ritonavir (Paxlovid) and molnupiravir in reducing SARS-CoV-2 Omicron hospitalizations and death, with one finding that the former is more effective than the latter at lowering death rates.
Following the first-ever head-of-state summit on pandemic preparedness at the United Nations (UN) General Assembly (yesterday), leaders approved a political declaration that spells out steps to better prepare the world for the next pandemic.
U.S. COVID infections are hovering near levels of the pandemic’s first peak in 2020, and approaching the Delta peak of late 2021, according to wastewater surveillance and modeling by forecasters. ...